Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 286085, 8 pages
http://dx.doi.org/10.1155/2014/286085
Review Article

Current State of Evidence for Medication Treatment of Preschool Internalizing Disorders

401c Erickson Hall, Michigan State University, East Lansing, MI 48824, USA

Received 30 August 2013; Accepted 10 November 2013; Published 27 January 2014

Academic Editors: V. Di Michele, J. Gonzalez, and T. Shioiri

Copyright © 2014 Justin A. Barterian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. T. Coyle, “Psychotropic drug use in very young children,” Journal of the American Medical Association, vol. 283, no. 8, pp. 1059–1060, 2000. View at Google Scholar · View at Scopus
  2. M. A. McDonnell and C. Glod, “Prevalence of psychopathology in preschool-age children,” Journal of Child and Adolescent Psychiatric Nursing, vol. 16, no. 4, pp. 141–152, 2003. View at Google Scholar · View at Scopus
  3. T. M. McGuinness, “How young is too young for psychotropic medication?” Journal of Psychosocial Nursing, vol. 45, pp. 20–23, 2007. View at Google Scholar
  4. D. A. Nardi and S. Barrett, “Potential effects of antidepressant agents on the growth & development of children & adolescents,” Journal of Psychosocial Nursing and Mental Health Services, vol. 43, no. 1, pp. 22–35, 2005. View at Google Scholar · View at Scopus
  5. J. S. Carlson, A. D. Mitchell, and N. Segool, “The current state of empirical support for the pharmacological treatment of selective mutism,” School Psychology Quarterly, vol. 23, no. 3, pp. 354–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Gleason, H. L. Egger, G. J. Emslie et al., “Psychopharmacological treatment for very young children: contexts and guidelines,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 46, no. 12, pp. 1532–1572, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. D. Rappley, “Actual psychotropic medication use in preschool children,” Infants and Young Children, vol. 19, no. 2, pp. 154–163, 2006. View at Google Scholar · View at Scopus
  8. N. K. Segool and J. S. Carlson, “Efficacy of cognitive-behavioral and pharmacological treatments for children with social anxiety,” Depression and Anxiety, vol. 25, no. 7, pp. 620–631, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. DeBar, F. Lynch, J. Powell, and J. Gale, “Psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization,” Archives of Pediatric and Adolescent Medicine, vol. 157, pp. 121–123, 2003. View at Google Scholar
  10. K. Minde, “The use of psychotropic medication in preschoolers: some recent developments,” Canadian Journal of Psychiatry, vol. 43, no. 6, pp. 571–575, 1998. View at Google Scholar · View at Scopus
  11. J. M. Zito, D. J. Safer, S. Valluri, J. F. Gardner, J. J. Korelitz, and D. R. Mattison, “Psychotherapeutic medication prevalence in Medicaid-insured preschoolers,” Journal of Child and Adolescent Psychopharmacology, vol. 17, no. 2, pp. 195–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Zito, D. J. Safer, S. DosReis, J. F. Gardner, M. Boles, and F. Lynch, “Trends in the prescribing of psychotropic medications to preschoolers,” Journal of the American Medical Association, vol. 283, no. 8, pp. 1025–1030, 2000. View at Google Scholar · View at Scopus
  13. Food and Drug Administration, “Medication guide for antidepressant drugs,” Washington, DC, USA, 2007,http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/ucm100211.pdf.
  14. H. L. Egger and A. Angold, “Common emotional and behavioral disorders in preschool children: presentation, nosology, and epidemiology,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 47, no. 3-4, pp. 313–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Luby, X. Si, A. C. Belden, M. Tandon, and E. Spitznagel, “Preschool depression: homotypic continuity and course over 24 months,” Archives of General Psychiatry, vol. 66, no. 8, pp. 897–905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. W. Lack, E. A. Storch, M. L. Keeley et al., “Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates,” Social Psychiatry and Psychiatric Epidemiology, vol. 44, no. 11, pp. 935–942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Van Ameringen, C. Mancini, and P. Farvolden, “The impact of anxiety disorders on educational achievement,” Journal of Anxiety Disorders, vol. 17, no. 5, pp. 561–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Scahill, V. Hamrin, and M. E. Pachler, “The use of selective serotonin reuptake inhibitors in children and adolescents with major depression,” Journal of Child and Adolescent Psychiatric Nursing, vol. 18, no. 2, pp. 86–89, 2005. View at Google Scholar · View at Scopus
  19. D. J. Safer and J. M. Zito, “Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents,” Journal of Child and Adolescent Psychopharmacology, vol. 16, no. 1-2, pp. 159–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Zuckerman, B. L. Vaughan, J. Whitney et al., “Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review,” Journal of Child and Adolescent Psychopharmacology, vol. 17, no. 2, pp. 165–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Brock, B. Nguyen, N. Liu, M. Watkins, and T. Reutzel, “The use of antidepressants in school-age children,” The Journal of School Nursing, vol. 21, no. 6, pp. 318–322, 2005. View at Google Scholar · View at Scopus
  22. J. Fanton and M. M. Gleason, “Psychopharmacology and preschoolers: a critical review of current conditions,” Child and Adolescent Psychiatric Clinics of North America, vol. 18, no. 3, pp. 753–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. American Academy of Child and Adolescent Psychiatry, “Practice parameter on the use of psychotropic medication in children and adolescents,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 9, pp. 961–973, 2009. View at Google Scholar · View at Scopus
  24. M. N. Pavuluri, D. B. Henry, J. A. Carbray, G. A. Sampson, M. W. Naylor, and P. G. Janicak, “A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 16, no. 3, pp. 336–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. E. S. Dummit III, R. G. Klein, N. K. Tancer, B. Asche, and J. Martin, “Fluoxetine treatment of children with selective mutism: an open trial,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 35, no. 5, pp. 615–621, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. D. H. Golwyn and C. P. Sevlie, “Phenelzine treatment of selective mutism in four prepubertal children,” Journal of Child and Adolescent Psychopharmacology, vol. 9, no. 2, pp. 109–113, 1999. View at Google Scholar · View at Scopus
  27. B. Harvey and M. Milne, “Pharmacotherapy of selective mutism: two case studies of severe entrenched mutism responsive to adjunctive treatment with fluoxetine,” Southern African Journal of Child and Adolescent Mental Health, vol. 10, pp. 59–66, 1998. View at Google Scholar
  28. H. H. Wright, M. L. Cuccaro, T. V. Leonhardt, D. F. Kendall, and J. H. Anderson, “Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 34, no. 7, pp. 857–862, 1995. View at Google Scholar · View at Scopus
  29. M. Coskun and S. Zoroglu, “Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 19, no. 3, pp. 297–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Ercan, R. Kandulu, and U. Ardic, “Preschool children with obsessive-compulsive disorder and fluoxetine treatment,” European Child and Adolescent Psychiatry, vol. 21, pp. 169–172, 2012. View at Google Scholar
  31. A. Avci, R. S. Diler, and L. Tamam, “Fluoxetine treatment in a 2.5-year-old girl,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 37, no. 9, pp. 901–902, 1998. View at Google Scholar · View at Scopus
  32. G. Celik, R. S. Diler, A. Y. Tahiroglu, and A. Avci, “Fluoxetine in posttraumatic eating disorder in 2-year-old twins,” Journal of Child and Adolescent Psychopharmacology, vol. 17, no. 2, pp. 233–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. S. Carlson, T. R. Kratochwill, and H. F. Johnston, “Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial,” Journal of Child and Adolescent Psychopharmacology, vol. 9, no. 4, pp. 293–306, 1999. View at Google Scholar · View at Scopus
  34. O. Oner and P. Oner, “Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports,” Journal of Psychopharmacology, vol. 22, no. 7, pp. 809–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. B. J. McCabe-Sellers, C. G. Staggs, and M. L. Bogle, “Tyramine in foods and monoamine oxidase inhibitor drugs: a crossroad where medicine, nutrition, pharmacy, and food industry converge,” Journal of Food Composition and Analysis, vol. 19, pp. S58–S65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. L. Hanna, E. L. Feibusch, and K. J. Albright, “Buspirone treatment of anxiety associated with pharyngeal dysphagia in a four-year-old,” Journal of Child and Adolescent Psychopharmacology, vol. 7, no. 2, pp. 137–143, 1997. View at Google Scholar · View at Scopus
  37. J. L. Luby, A. C. Belden, J. Pautsch, X. Si, and E. Spitznagel, “The clinical significance of preschool depression: impairment in functioning and clinical markers of the disorder,” Journal of Affective Disorders, vol. 112, no. 1–3, pp. 111–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. L. Bergman, M. L. Keller, J. Piacentini, and A. J. Bergman, “The development and psychometric properties of the selective mutism questionnaire,” Journal of Clinical Child and Adolescent Psychology, vol. 37, no. 2, pp. 456–464, 2008. View at Publisher · View at Google Scholar · View at Scopus